Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases

Archives of Pharmacal Research

Volumn 32, Issue 8, 2009, Pages 1103-1108

  Napoli, Claudio ^a   Ignarro, Louis J ^b,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Konkuk University School of Medicine   (South Korea)

Author keywords

Atherosclerosis; Nitric oxide; Smooth muscle cells

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ANGIOTENSIN II; ARGINASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FENOFIBRATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; KRUPPEL LIKE FACTOR; KRUPPEL LIKE TRANSCRIPTION FACTOR 2; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD7 PROTEIN; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTERIAL WALL THICKNESS; ATHEROGENESIS; ATHEROSCLEROSIS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PATHOGENESIS; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REVIEW; RISK FACTOR; VASCULAR DISEASE;

ANIMALS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; VASCULAR DISEASES;

EID: 69949111623     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1801-1     Document Type: Review

References (36)

1. G. B. Atkins M. K. Jain 2007 Role of krüppel-like transcription actors in endothelial biology Circ. Res. 100 1686 16895
2. R. A. Boon J. O. Fledderus O. L. Volger E. J. van Wanrooij E. Pardali F. Weesie J. Kuiper H. Pannekoek P. ten Dijke A. J. Horrevoets 2007 KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1 Arterioscler. Thromb. Vasc. Biol. 27 532 539
3. M. A. Bouhlel B. Staels G. Chinetti-Gbaguidi 2008 Peroxisome proliferator-activated receptors-from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease J. Intern. Med. 263 28 42
4. S. Cao J. Yao V. Shah 2003 The proline-rich domain of dynamin-2 is responsible for dynamin-dependent in vitro potentiation of endothelial nitric-oxide synthase activity via selective effects on reductase domain function J. Biol. Chem. 278 5894 5901
5. F. P. D'Armiento A. Bianchi F. De Nigris D. M. Capuzzi M. R. D'Armiento G. Crimi P. Abete W. Palinski M. Condorelli C. Napoli 2001 Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classical risk factors for atherosclerosis Stroke 32 2472 2479
6. F. de Nigris A. Lerman L. J. Ignarro S. Ignarro-Williams V. Sica A. H. Baker L. O. Lerman Y. J. Geng C. Napoli 2003 Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis Trends. Mol. Med. 9 351 359
7. R. J. Dekker R. A. Boon M. G. Rondaij A. Kragt O. L. Volger Y. W. Elderkamp J. C. Meijers J. Voorberg H. Pannekoek A. J. Horrevoets 2006 KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium Blood 107 4354 4363
8. R. J. Dekker J. V. van Thienen J. Rohlena S. C. de Jager Y. W. Elderkamp J. Seppen C. J. de Vries E. A. Biessen T. J. van Berkel H. Pannekoek A. J. Horrevoets 2005 Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes Am. J. Pathol. 167 609 618
9. A. K. Doughan D. G. Harrison S. I. Dikalov 2008 Molecular mechanisms of angiotensin II mediated mitochondrial dysfunction. linking mitochondrial oxidative damage and vascular endothelial dysfunction Circ. Res. 102 488 496
10. J. O. Fledderus J. V. van Thienen R. A. Boon R. J. Dekker J. Rohlena O. L. Volger A. P. Bijnens M. J. Daemen J. Kuiper T. J. van Berkel H. Pannekoek A. J. Horrevoets 2007 Prolonged shear stress and KLF2 suppress constitutive pro-inflammatory transcription through inhibition of ATF2 Blood 109 4249 4257
11. G. Garcia-Cardena R. Fan V. Shah R. Sorrentino G. Cirino A. Papapetropoulos W. C. Sessa 1998 Dynamic activation of endothelial nitric oxide synthase by Hsp90 Nature 392 821 824
12. B. L. Goodwin L. P. Solomonson D. C. Eichler 2004 Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells J. Biol. Chem. 279 18353 18360
13. K. Goya S. Sumitani X. Xu T. Kitamura H. Yamamoto S. Kurebayashi H. Saito H. Kouhara S. Kasayama I. Kawase 2004 Peroxisome proliferator-activated receptor α agonists increase nitric oxide synthase expression in vascular endothelial cells Arterioscler. Thromb. Vasc. Biol. 24 658 663
14. T. Hayashi P. A. Juliet A. Miyazaki L. J. Ignarro A. Iguchi 2007 High glucose downregulates the number of caveolae in monocytes through oxidative stress from NADPH oxidase: Implications for atherosclerosis Biochim. Biophys. Acta. 1772 364 372
15. L. J. Ignarro G. Cirino A. Casini C. Napoli 1999 Nitric oxide as a signaling molecule in the vascular system: An overview J. Cardiovasc. Pharmacol. 34 879 886
16. L. J. Ignarro C. Napoli J. Loscalzo 2002 Nitric oxidedonating compounds and cardiovascular agents modulating the bioactivity of nitric oxide: An overview Circ. Res. 90 21 28
17. L. J. Ignarro C. Napoli 2004 Novel features on nitric oxide, endothelial nitric oxide synthase and atherosclerosis Curr. Atheroscler. Rep. 6 278 287
18. Z. Israelian-Konaraki P. D. Reaven 2005 Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications Cardiol Rev. 13 240 246 (Pubitemid 41197252)
19. S. Lavi E. H. Yang A. Prasad V. Mathew G. W. Barsness C. S. Rihal L. O. Lerman A. Lerman 2008 The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans Hypertension 51 127 133
20. E. J. Lim E. J. Smart M. Toborek B. Hennig 2007 The role of caveolin-1 in PCB77-induced eNOS phosphorylation in human-derived endothelial cells Am. J. Physiol. Heart. Circ. Physiol. 293 H3340 H3347
21. Z. Lin A. Kumar S. Senbanerjee K. Staniszewski K. Parmar D. E. Vaughan M. A. Gimbrone Jr V. Balasubramanian G. Garcia-Cardena M. K. Jain 2005 Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function Circ. Res. 96 e48 e57
22. V. W. T. Liu P. L. Huang 2008 Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted mice Cardiovasc. Res. 77 19 29
23. N. A. Maniatis V. Brovkovych S. E. Allen T. A. John A. N. Shajahan C. Tiruppathi S. M. Vogel R. A. Skidgel A. B. Malik R. D. Minshall 2006 Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells Circ. Res. 99 870 877
24. C. Napoli F. de Nigris S. Williams-Ignarro O. Pignalosa V. Sica L. J. Ignarro 2006 Nitric oxide and atherosclerosis: An update Nitric Oxide 15 265 279
25. C. Napoli L. J. Ignarro 2001 Nitric oxide and atherosclerosis Nitric Oxide 5 88 97
26. C. Napoli L. J. Ignarro 2003 Nitric oxide-releasing drugs Annu. Rev. Pharmacol. Toxicol. 43 97 123
27. C. Napoli L. J. Ignarro 2007 Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis J. Clin. Pathol. 60 341 344
28. C. Napoli L. O. Lerman F. De Nigris J. Loscalzo L. J. Ignarro 2002 Glyoxidized low-density lipoprotein down regulates endothelial nitric oxide synthase in human coronary cells J. Am. Coll. Cardiol. 40 1515 1522
29. C. Napoli L. O. Lerman 2001 Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia Mayo Clin. Proc. 76 619 631
30. C. Napoli R. Paterno F. M. Faraci H. Taguchi A. Postiglione D. D. Heistad 1997 Mildly oxidized low-density lipoprotein impairs responses of carotid but not basilar artery in rabbits Stroke 28 2266 2272
31. C. Napoli J. L. Witztum F. De Nigris G. Palumbo F. P. D'Armiento W. Palinski 1999 Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries Circulation 99 2003 2010
32. K. M. Parmar H. B. Larman G. Dai Y. Zhang E. T. Wang S. N. Moorthy J. R. Kratz Z. Lin M. K. Jain M. A. Gimbrone Jr G. Garcia-Cardena 2006 Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2 J. Clin. Invest. 116 49 58
33. K. M. Parmar V. Nambudiri G. Dai H. B. Larman M. A. Gimbrone Jr G. Garcia-Cardena 2005 Statins exert endothelial atheroprotective effects via the KLF2 transcription factor J. Biol. Chem. 280 26714 26719
34. T. J. Rabelink T. F. Luscher 2006 Endothelial Nitric Oxide Synthase: Host defense enzyme of the endothelium? Arterioscler. Thromb. Vasc. Biol. 26 267 271
35. E. L. Schiffrin 2008 Oxidative stress, nitric oxide synthase, and superoxide dismutase: A matter of imbalance underlies endothelial dysfunction in the human coronary circulation Hypertension 51 31 32
36. S. Sen-Banerjee Z. Lin G. B. Atkins D. M. Greif R. M. Rao A. Kumar M. W. Feinberg Z. Chen D. I. Simon F. W. Luscinskas T. M. Michel M. A. Gimbrone Jr G. Garcia-Cardena M. K. Jain 2004 KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation J. Exp. Med. 199 1305 1315